CN120826236A - 脂质纳米粒子、医药组合物以及脂质纳米粒子的制造方法 - Google Patents

脂质纳米粒子、医药组合物以及脂质纳米粒子的制造方法

Info

Publication number
CN120826236A
CN120826236A CN202480016036.0A CN202480016036A CN120826236A CN 120826236 A CN120826236 A CN 120826236A CN 202480016036 A CN202480016036 A CN 202480016036A CN 120826236 A CN120826236 A CN 120826236A
Authority
CN
China
Prior art keywords
lipid
polymer
protein
igg
lnp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480016036.0A
Other languages
English (en)
Chinese (zh)
Inventor
川口祥正
二木史朗
平井勇祐
广濑久昭
笠原千圣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research And Development Corp Science And Technology Revitalization Organization
Original Assignee
National Research And Development Corp Science And Technology Revitalization Organization
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research And Development Corp Science And Technology Revitalization Organization filed Critical National Research And Development Corp Science And Technology Revitalization Organization
Publication of CN120826236A publication Critical patent/CN120826236A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/80—Immunoglobulins specific features remaining in the (producing) cell, i.e. intracellular antibodies or intrabodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
CN202480016036.0A 2023-03-02 2024-03-04 脂质纳米粒子、医药组合物以及脂质纳米粒子的制造方法 Pending CN120826236A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023-031510 2023-03-02
JP2023031510 2023-03-02
PCT/JP2024/008154 WO2024181580A1 (ja) 2023-03-02 2024-03-04 脂質ナノ粒子、医薬組成物、および脂質ナノ粒子の製造方法

Publications (1)

Publication Number Publication Date
CN120826236A true CN120826236A (zh) 2025-10-21

Family

ID=92589996

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480016036.0A Pending CN120826236A (zh) 2023-03-02 2024-03-04 脂质纳米粒子、医药组合物以及脂质纳米粒子的制造方法

Country Status (4)

Country Link
EP (1) EP4674431A1 (https=)
JP (1) JPWO2024181580A1 (https=)
CN (1) CN120826236A (https=)
WO (1) WO2024181580A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
RU2474585C2 (ru) 2007-01-22 2013-02-10 Дженентек, Инк. Осаждение и очистка белков полиэлектролитами
WO2009026122A1 (en) * 2007-08-17 2009-02-26 Amgen Inc. Formulations of antibodies and fc-fusion molecules using polycations
BR122020023215B1 (pt) 2013-05-03 2022-11-22 Selecta Biosciences, Inc Composição e kit de nanocarreadores sintéticos tolerogênicos para reduzir ou prevenir anafilaxia em resposta a um antígeno não alergênico
JP6444310B2 (ja) 2013-10-28 2018-12-26 テルモ株式会社 モノクローナル抗体の安定化方法
CA3092338A1 (en) * 2018-01-29 2019-08-01 The Johns Hopkins University Polymeric nanoparticle compositions for encapsulation and sustained release of protein therapeutics
CN111902397B (zh) 2018-03-27 2024-04-12 日油株式会社 改进了细胞内动力学的阳离子脂质

Also Published As

Publication number Publication date
WO2024181580A1 (ja) 2024-09-06
JPWO2024181580A1 (https=) 2024-09-06
EP4674431A1 (en) 2026-01-07

Similar Documents

Publication Publication Date Title
Rajapaksa et al. Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery
Torchilin et al. pH-sensitive liposomes
JP6407208B2 (ja) 合成ナノキャリア混合ワクチン
US20240207186A1 (en) Nanolipoprotein particles and related compositions methods and systems for loading rna
JP5835741B2 (ja) 抗原または薬物送達複合体
JP2017502997A (ja) ハイブリドソーム、それを含む組成物、それらの製造方法、およびその使用
JP2014532071A (ja) カーゴの経皮送達を含む標的送達用の多孔性ナノ粒子に担持された脂質二重層（プロトセル）及びその方法
CN115025061B (zh) 基于可穿透血脑屏障的去毒细菌外膜包裹的脑靶向仿生纳米给药系统及其制备方法和应用
JPWO2007037444A1 (ja) 目的物質を核内又は細胞内に送達するためのベクター
CN103037840A (zh) 具有核内转运性的脂质膜结构体
TWI663991B (zh) 薄殼聚合物奈米粒子及其用途
Kalra et al. Virosomes: as a drug delivery carrier
US20190117572A1 (en) Microfluidic-formulated leukosome compositions and fabrication methods therefor
JP2025502796A (ja) Ｒｎａの投与のための脂質ベースの製剤
EP3678706A1 (en) Albumin-modified nanoparticles carrying a targeting ligand
Cheng et al. Enhanced opsonization-independent phagocytosis and high response ability to opsonized antigen–antibody complexes: a new role of kupffer cells in the accelerated blood clearance phenomenon upon repeated injection of PEGylated emulsions
EP4442256A1 (en) Lipid nanoparticle compositions
WO2013140643A1 (ja) 機能性タンパク質を細胞内に送達するためのキャリア
JPWO2011135905A1 (ja) 脂質膜構造体
US20230398207A1 (en) Modulating th1/th2 immune response by administering two populations of polymersomes having an associated antigen and an associated adjuvant
US20230256082A1 (en) Vaccine against human-pathogenic coronaviruses
JP5067733B2 (ja) 目的物質をミトコンドリア内に送達可能な脂質膜構造体
CN120826236A (zh) 脂质纳米粒子、医药组合物以及脂质纳米粒子的制造方法
US20160158154A1 (en) Protein vesicles and methods of making and using thereof
Herringson et al. Targeting of plasmid DNA‐lipoplexes to cells with molecules anchored via a metal chelator lipid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination